ThomasMPisanskyMD

Radiation Oncology • Rochester, MN

Breast Cancer, Urologic Cancer

Professor, Oncology, Mayo Medical School

Join to view full profile

Dr. Pisansky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pisansky's full profile

Already have an account?

Office
200 1st St Sw
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Residency, Radiation Oncology, 1984 - 1987
Hennepin HealthcareResidency, Internal Medicine, 1980 - 1984
University of Minnesota Medical SchoolClass of 1980

Certifications & Licensure

AZ State Medical License 1988 - Present
MN State Medical License 1982 - 2024
FL State Medical License 1987 - 2000
American Board of Internal Medicine Internal Medicine
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus Start of enrollment: 1995 Jun 01
Completed
Phase 3
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Start of enrollment: 2002 Feb 01
Completed
Phase 2
Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer Start of enrollment: 2008 Aug 01
Completed
Phase 2
Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer Start of enrollment: 2017 May 12
Active, not recruiting
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer Start of enrollment: 2012 Jul 25
Active, not recruiting
Not Applicable
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Five-year outcomes of moderately hypofractionated proton therapy incorporating elective pelvic nodal irradiation for high-risk prostate cancer.
Richard Choo, Kimberly Corbin, Kenneth Merrell, Bradley Stish, Thomas M Pisansky
International Journal of Radiation Oncology, Biology, Physics. 2024-12-11
Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized P...
Amy J Wisdom, Beow Y Yeap, Jeff M Michalski, Nora K Horick, Anthony L Zietman
International Journal of Radiation Oncology, Biology, Physics. 2024-09-30
2 citations
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.
W Robert Lee, James J Dignam, Mahul B Amin, Deborah W Bruner, Daniel Low
Journal of Clinical Oncology. 2024-07-10

Journal Articles

Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results from the Internationa...
Michael J Zelefsky, Matthew R Cooperberg, Brian J Davis, Eric M Horwitz, Martha K Terris, Christopher L Amling, Christopher J Kane, Curtiland Deville, Theodore L Dewee..., JAMA Oncology
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological Features
Rahul D. Tendulkar, Kevin L. Stephans, Stanley L. Liauw, Robert B. Den, Shre Agrawal, Mitchel S. Anscher, Jason A. Efstathiou, Thomas M. Pisansky, Jason W. Hearn, Jef ..., JAMA

Press Mentions

Study Finds Stereotactic Body Radiotherapy Is Safe for Treating Patients with Multiple MetastasesApril 21st, 2021
Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline (2013, Amended 2018 & 2019)June 4th, 2019